Health Care

Sep 9, 2013

Dismissing the chatter as Pfizer reorganizes itself

The pharmaceutical industry is in a constant state of flux, led by a regular wave of consolidation and occasional spinoffs.

Sep 9, 2013

Tax credit is ‘an important carrot’ for early-stage biotechs

Soligenix Inc. hasn't claimed benefits from the Orphan Drug Tax Credit because the pre-revenue company has yet to generate taxable profits.

Sep 9, 2013

For generics companies, key to survival is a rapid response time

When William Kennally switched from the brand side of the pharmaceuticals business to generics 13 years ago, his colleagues kidded that he was joining the dark side.

Sep 9, 2013

Skiing accident kicks entrepreneur into new career

A dangerous skiing accident at Lake Tahoe propelled Steve Llorens on a new career path — from lawyer to entrepreneur.

Sep 9, 2013

Hard to swallow

When NPS Pharmaceuticals received federal approval to sell Gattex earlier this year, it was great news for those who suffer from short-bowel syndrome — a very rare disease.
It also was great news for the Bedminster company, which stands to benefit from $50 million in tax credit for developing this so-called orphan drug.

Sep 6, 2013

Coalition plans to demonstrate in support of paid sick-leave requirement

Jersey City Mayor Steven Fulop's sick-leave proposal — under which employers with more than 10 employees must allow both full and part-time workers to accrue five paid sick days a year — is causing a stir well before the measure goes before the city council Wednesday.

Sep 6, 2013

Capsugel acquiring Bend Research

Morristown-based dosage solution company Capsugel announced Thursday it will acquire Oregon-based Bend Research.

Sep 5, 2013

Sanofi licenses Pozen cardio drugs in deal worth at least 15M

Sanofi U.S. has signed an exclusive licensing agreement with Pozen Inc. to commercialize the pharmaceutical company's investigational cardiovascular drugs, PA8140 and PA32540.

Sep 5, 2013

Derma Sciences acquires 7.3 percent of Comvita

Princeton-based advanced wound care company Derma Sciences announced Wednesday it has purchased 2.3 million newly issued common shares of New Zealand-based health and beauty company Comvita Limited for $7 million. The investment amounts to 7.3 percent of outstanding Comvita shares.

Sep 5, 2013

Delta Dental names new CEO

Parsippany-based Delta Dental of New Jersey announced Wednesday it named Dennis Wilson its new president and CEO. Wilson is replacing Walter VanBrunt, who is retiring after serving as CEO for the past 15 years.

Sep 5, 2013

Rockwood completes 1.96B CeramTec sale

Princeton-based specialty chemicals company Rockwood Holdings Inc. announced Wednesday it has completed its sale of German ceramics producer CeramTec to European private equity firm Cinven for € 1.49 billion ($1.96 billion).

Sep 4, 2013

C.R. Bard acquiring Rochester Medical in 262 million deal

C.R. Bard Inc. has agreed to acquire Rochester Medical Inc., a developer and supplier of silicone urinary incontinence and urine drainage products, for about $262 million, or $20 a share.